The FDA has approved the combination of nivolumab plus chemotherapy as first-line treatment for certain patients with stage III or IV classical Hodgkin lymphoma.The approval, for individuals aged 12 ...
When Kevin Tougher was diagnosed with nasal cavity cancer at 39, he faced the possibility of losing his nose to surgery. A groundbreaking treatment at MSK changed everything—preserving both his health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results